156 related articles for article (PubMed ID: 36393917)
1. Incidence, Timing, and Causes of Late Bleeding After TAVR in an Asian Cohort.
Yamamoto M; Otsuka T; Shimura T; Yamaguchi R; Adachi Y; Kagase A; Tokuda T; Tsujimoto S; Koyama Y; Yashima F; Tada N; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Mizutani K; Tabata M; Ueno H; Takagi K; Watanabe Y; Hayashida K;
JACC Asia; 2022 Oct; 2(5):622-632. PubMed ID: 36393917
[TBL] [Abstract][Full Text] [Related]
2. Late Bleeding Events in Patients Undergoing Percutaneous Coronary Intervention in the Workup Pre-TAVR.
Avvedimento M; Campelo-Parada F; Munoz-Garcia E; Nombela-Franco L; Fischer Q; Donaint P; Serra V; Veiga G; Gutiérrez E; Esposito G; Vilalta V; Alperi A; Regueiro A; Asmarats L; Ribeiro HB; Matta A; Munoz-Garcia A; Tirado-Conte G; Urena M; Metz D; Rodenas-Alesina E; de la Torre Hernandez JM; Fernandez-Nofrerias E; Pascual I; Vidal-Cales P; Arzamendi D; Campanha-Borges DC; Trinh KH; Côté M; Faroux L; Rodés-Cabau J
JACC Cardiovasc Interv; 2023 Sep; 16(17):2153-2164. PubMed ID: 37704301
[TBL] [Abstract][Full Text] [Related]
3. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.
Nombela-Franco L; del Trigo M; Morrison-Polo G; Veiga G; Jimenez-Quevedo P; Abdul-Jawad Altisent O; Campelo-Parada F; Biagioni C; Puri R; DeLarochellière R; Dumont E; Doyle D; Paradis JM; Quirós A; Almeria C; Gonzalo N; Nuñez-Gil I; Salinas P; Mohammadi S; Escaned J; Fernández-Ortiz A; Macaya C; Rodés-Cabau J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1748-57. PubMed ID: 26476610
[TBL] [Abstract][Full Text] [Related]
6. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
Sherwood MW; Vora AN
Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
[TBL] [Abstract][Full Text] [Related]
7. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR.
Dietrich L; Kibler M; Matsushita K; Marchandot B; Trimaille A; Reydel A; Diop B; Truong PD; Trung AM; Trinh A; Carmona A; Hess S; Jesel L; Ohlmann P; Morel O
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011952
[TBL] [Abstract][Full Text] [Related]
8. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
[TBL] [Abstract][Full Text] [Related]
10. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
[TBL] [Abstract][Full Text] [Related]
12. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
[TBL] [Abstract][Full Text] [Related]
14. Trends in vascular complications and associated treatment strategies following transfemoral transcatheter aortic valve replacement.
Ullery BW; Jin R; Kirker EB; Hayes G; Siwek L; Brevig J; Hodson RW; Spinelli KJ
J Vasc Surg; 2020 Oct; 72(4):1313-1324.e5. PubMed ID: 32169358
[TBL] [Abstract][Full Text] [Related]
15. Staged versus concomitant transcatheter aortic valve replacement and percutaneous coronary intervention: A national analysis.
Tran Z; Hadaya J; Downey P; Sanaiha Y; Verma A; Shemin RJ; Benharash P
JTCVS Open; 2022 Jun; 10():148-161. PubMed ID: 36004248
[TBL] [Abstract][Full Text] [Related]
16. Short-term dual anti-platelet therapy decreases long-term cardiovascular mortality after transcatheter aortic valve replacement.
Hioki H; Watanabe Y; Kozuma K; Kataoka A; Yashima F; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Mizutani K; Tabata M; Takagi K; Ueno H; Yamamoto M; Hayashida K;
Heart Vessels; 2021 Feb; 36(2):252-259. PubMed ID: 32880683
[TBL] [Abstract][Full Text] [Related]
17. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.
Généreux P; Cohen DJ; Mack M; Rodes-Cabau J; Yadav M; Xu K; Parvataneni R; Hahn R; Kodali SK; Webb JG; Leon MB
J Am Coll Cardiol; 2014 Dec; 64(24):2605-2615. PubMed ID: 25524339
[TBL] [Abstract][Full Text] [Related]
18. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
[TBL] [Abstract][Full Text] [Related]
19. Late Cerebrovascular Events Following Transcatheter Aortic Valve Replacement.
Muntané-Carol G; Urena M; Munoz-Garcia A; Padrón R; Gutiérrez E; Regueiro A; Serra V; Capretti G; Himbert D; Moris C; Sabaté M; Garcia Del Blanco B; Ferreira-Neto AN; Coté M; Fischer Q; Couture T; Kalavrouziotis D; Rodés-Cabau J
JACC Cardiovasc Interv; 2020 Apr; 13(7):872-881. PubMed ID: 32171718
[TBL] [Abstract][Full Text] [Related]
20. Impact of new-onset versus pre-existing atrial fibrillation on outcomes after transcatheter aortic valve replacement/implantation.
Nso N; Emmanuel K; Nassar M; Bhangal R; Enoru S; Iluyomade A; Marmur JD; Ilonze OJ; Thambidorai S; Ayinde H
Int J Cardiol Heart Vasc; 2022 Feb; 38():100910. PubMed ID: 35146118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
